The results, along with the Dupixent Phase 3 trials, demonstrated patients taking Dupixent experienced improvements in signs and symptoms of atopic dermatitis ... skin rash, swollen lymph nodes ...

There are many other types of rashes with a wide variety of causes. Treatment for a rash requires the correct diagnosis and can include medication and avoiding potential triggers.  Easily ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

Bojungikgi-tang improved anorexia and atopic dermatitis symptoms in a randomized trial, with effects linked to gut microbiome ...

A Google search on “diet and eczema” may be more misleading than helpful, warns pediatric dermatologist Sandipan Dhar.

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

How much do parents understand about their child's atopic dermatitis? Megan Rogge, MD, of UT Health in Houston emphasizes the importance of counseling parents and caregivers on how to follow a ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

The results, along with the Dupixent Phase 3 trials, demonstrated patients taking Dupixent experienced improvements in signs and symptoms of atopic dermatitis from baseline across many skin tones.

"Atopic dermatitis, a chronic disease with underlying type 2 inflammation ... and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings ...